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Abstract: Intraarticular injection of streptococ-
cal cell wall (SCW) antigen followed by intravenous
challenge results in a T cell-mediated monoarticu-
lar arthritis in female Lewis rats. Initial studies
showed that this reactivation response to intrave-
nous SCW antigen is dependent on the presence of
interleukin-1 (IL-1) and tumor necrosis factor a
(TNF-a) and that the early phase of swelling is
neutrophil-dependent. Neutrophil depletion or pas-
sive immunization with antibodies to P-selectin or
macrophage inflammatory protein-2 reduced the
intensity of ankle edema and the influx of neutro-
phils. After the first few days, however, the arthritic
response is mediated primarily by mononuclear
cells. Joint tissues showed up-regulation of mRNA
for monocyte chemotactic protein-1 (MCP-1),
which could be inhibited in part by anti-IL-4;
treatment of rats with antibodies to IL-4 or MCP-1
significantly suppressed development of ankle
edema and histopathological evidence of inflamma-
tion. Antibodies to interferon-g or IL-10 had no
effect. Treatment with anti-MCP-1 also suppressed
influx of 111In-labeled T cells into the ankle joint.
These data suggest that the late, mononuclear-
dependent phase of SCW-induced arthritis in fe-
male Lewis rats requires cytokines that up-regulate
MCP-1, which in turn may facilitate recruitment
and extravasation of mononuclear cells into the
joint. J. Leukoc. Biol. 63: 359–363; 1998.
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INTRODUCTION
Rheumatoid arthritis is a prevalent chronic inflammatory
disease in which large numbers of mononuclear cells infiltrate
the synovial tissue. In addition, large numbers of neutrophils
accumulate in the synovial fluid and neutrophil-related media-
tors are elevated in the joint. Although many cell types may be
involved in the pathophysiology of the disease, the interrelation-
ship of various mediators and cells is not well defined. It is
known that migration of inflammatory cells into tissues is a
pivotal aspect of arthritis and other inflammatory diseases and
is regulated by a complex process involving a host of adhesion
molecules and cellular mediators [1–4]. The first step in this
cellular cascade involves a tentative interaction between the
leukocyte and the endothelial wall of the vasculature. Depend-
ing on the cell type, specific adhesion molecules and cytokines
are elicited which allow tethering and then more firm leukocyte
attachment in preparation for eventual emigration into the
extravascular space. Other cytokines and adhesion molecules
help create an opportunity for the cells to enter an inflammatory
site and display a range of effector functions.
One complexity in the study of arthritic processes is the lack
of synchronized chronic animal models. In most models the
arthritic response develops gradually and unpredictably over a
period of days or weeks. Understanding the temporal interrela-
tionships of various mediator systems is more practical when
the various phases of the inflammatory response occur simulta-
neously. Therefore, a model of arthritis was developed that is
induced by intraarticular (i.a.) injection into an ankle joint of a
small dose of purified peptidoglycan-polysaccharide polymers
isolated from cell walls of group A streptococci (PG-APS),
producing a synovitis with maximal swelling at 24 h that
subsides over the next few days. The response is reactivated by
an intravenous injection of a small subarthropathic dose of
PG-APS, which produces a more prolonged, severe inflamma-
tion confined to the joint previously injured with PG-APS. The
flare response develops synchronously, allowing precise defini-
tion of regulatory mechanisms [5–9]. Although T cell depen-
dency has been demonstrated in cellular studies, a precise role
for T cells has not been elucidated [10].
In this report we describe the results of studies done to
evaluate the role and interrelationship of cytokines, adhesion
molecules, and chemokines in the arthritic response induced
by reactivation with PG-APS. The results indicate that the
model is neutrophil dependent and that interleukin-1 (IL-1)
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and tumor necrosis factor (TNF) are essential for full expression
of the arthritic response. Moreover, antibodies to IL-4, but not
interferon-g, block swelling when administered during the
reactivation phase. The results also show that antibodies to IL-4
reduce mRNA for MCP-1, perhaps helping to explain the IL-4
dependence of the model. Finally, antibodies to MCP-1 block
swelling and T cell influx into the joint, suggesting an important




Except as noted, all reagents were purchased from Sigma Chemical Co. (St.
Louis, MO). The 100p fraction of the streptococcal preparation (PG-APS) was
purchased from Lee Laboratories (Grayson, GA). The material was briefly
sonicated in a Branson Sonifier, Model 200. Antibodies against rat TNF-a,
macrophage inflammatory protein-1a (MIP-1a), and IL-1 were generously
provided by Dr. S. Kunkel, University of Michigan. Recombinant murine IL-4
and IL-10 were expressed in Escherichia coli and purified to homogeneity and
high specific activity as previously described [11]. Rabbits were immunized
with recombinant murine IL-4 and IL-10 in complete Freund’s adjuvant.
Production of antibody to rat MCP-1 has been described elsewhere [12]. A
purified IgG preparation was made from the anti MCP-1 antiserum with the use
of a Protein A Sepharose-4 fast flow column (Pharmacia, Uppsala, Sweden).
Anti-interferon-g was produced in goats after immunization with rat inter-
feron-g. An IgG preparation was made as described above. Antibody to MIP-2
similarly was raised in rabbits by immunization with recombinant rat MIP-2
protein [13]. For interventions involving antisera, 0.5 mL of antiserum or
control rabbit serum (Lampire Biological Laboratories; Pipersville, PA) was
injected intravenously 20 min before systemic injection of streptococcal cell
wall (SCW). On days 1 and 2 after reactivation the animals were given daily
intravenous doses of 0.25 mL of antiserum or control serum. A loading dose of
500 µg of anti-MCP-1, anti-interferon-g, or appropriate control IgG was
administered before intravenous challenge with SCW. On days 1 and 2 after
reactivation the animals were given daily intravenous doses of 250 µg of
antibody or control IgG.
Animals
Female Lewis rats (100–125 g) were purchased from Charles River Laborato-
ries (Portage, MI) and housed in the animal quarters of Parke, Davis
Pharmaceutical Research (Ann Arbor, MI). All animal protocols were approved
by the Parke, Davis Institutional Animal Care and Use Committee. Rats were
given food and water ad libitum.
Animal model of SCW-induced arthritis
SCW-induced arthritis was induced as previously described [7]. A SCW
preparation (100 p fraction) was suspended in phosphate-buffered saline (PBS)
and 10 µL of the suspension containing 6 µg PG-APS was injected into one
ankle joint; the contralateral joint was injected with PBS. Swelling was
measured by mercury plethysmography. Reactivation of the arthritic inflamma-
tion was induced 21 days after the intraarticular injection by the intravenous
injection of 100 µg PG-APS. This resulted in a monoarticular arthritis involving
the joint originally injected with PG-APS. Blocking antibody treatments were
performed by tail vein injection of appropriate Ig’s. Seven animals per group
were used in each study and two rats from each group were killed for
histological assessment at 72 h after flare-up.
Histological techniques
When rats were killed, the ankles were injected intraarticularly with 20 µL of
10% neutral buffered formalin, removed, skinned, and fixed for another 24 h in
buffered formalin. Before paraffin embedding, the joints were decalcified in
10% ethylenediaminetetraacetate (EDTA) for 7 days. Paraffin sections were
stained in Safranin-O for cartilage proteoglycan and counter-stained with fast
green and hematoxylin.
Whole ankle RNA extraction
Ankles were harvested, skinned, and immediately flash frozen in liquid
nitrogen. The ankles were ground into fine powder using a tissue pulverizer
(Biospec Products, Bartlesville, OK) continuously cooled in liquid nitrogen.
The resulting tissue powder was homogenized in Trizol reagent using a tissue
homogenizer (Ultra-Turrax T25, Janke & Kunkel) in three 10-s steps with
intermittent cooling of the sample in liquid nitrogen. RNA extraction was then
performed by phase separation using Trizol reagent (GIBCO-BRL, Bethesda,
MD) and chloroform and subsequent RNA precipitation by isopropanol. The
resulting pellet was air dried, washed in 75% ethanol, and dissolved in 100 µL
of TE buffer.
Northern blot analysis
Ten micrograms RNA from each tissue preparation were electrophoretically
separated through a denaturing agarose/formaldehyde gel followed by capillary
transfer to nylon membranes. The membranes were washed in distilled H2O and
subsequently dried in vacuo at 80°C for 2 h. Prehybridization was performed at
65°C for 1 h in 7% sodium dodecyl sulfate (SDS), 500 mM NaHPO3, 1 mM
EDTA, and 1% (w/v) bovine serum albumin (BSA) followed by hybridization to
32P-labeled cDNA probes at 65°C overnight in the above buffer with 100
mg/mL of salmon sperm DNA and 106 cpm/mL probe. Filters were then washed
at 65°C for 10 min in 5% SDS, 25 mM NaHPO, 1 mM EDTA, and 0.5% BSA
followed by two washing steps in 1% SDS, 25 mM NaHPO, 1 mM EDTA, and
exposure to XAR5 film (Kodak) at 285°C. Densitometry measurements were
made with a densitometer equipped with ImageQuant software (V. 3.3) by
Molecular Dynamics (Sunnyvale, CA).
Statistics
One- or two-way analysis of variance was employed together with a Student’s
t-test to evaluate statistical differences among experimental groups.
RESULTS AND DISCUSSION
Role of neutrophils, TNF-a, and IL-1 in arthritis
induced by PG-APS in the reactivation model
To examine the role of neutrophils in the model, anti-neutrophil
or appropriate control antibodies were administered to animals
1 day before reactivation of the arthritic response, and for two
subsequent days after reactivation. The rats had been immu-
nized in one hind paw with the cell wall preparation 21 days
earlier. Circulating neutrophil counts and extravasation of
neutrophils into the synovial fluid were almost completely
suppressed during the reactivation period. Neutrophil deple-
tion also inhibited swelling for 3 days after reactivation
(Fig. 1). Inhibition was maximal on day 2 (84% inhibition,
P , 0.05). Consistent with these observations, antibodies to
P-selectin also significantly inhibited swelling (data not shown).
To evaluate the role of TNF-a and IL-1 in the reactivation
model, antibodies were administered as described above.
Appropriate control antibodies were used in each instance.
Results shown in Figure 1 indicate that antibodies to either
TNF-a or IL-1 almost completely suppressed the inflammatory
response in the hind paws 72 h after reactivation. Inhibition
was sustained throughout the observation period. Histopathologi-
cal analysis indicated a significant reduction in the pansynovial
infiltration of mononuclear cells.
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These observations parallel those from collagen arthritis
(CIA) and the chronic SCW paradigms. In CIA, the IL-1
receptor antagonist decreased the severity of arthritis during
the acute phase [7, 14], as did antibodies against IL-1b [15,
16]. In contrast, IL-1 does not play a role in antigen-induced
arthritis in mice and rabbits [14, 17]. TNF-a is a proinflamma-
tory cytokine that has been proven to be involved in many
animal models of arthritis. The dependence of TNF-a in CIA
was shown by Wooley et al. [18] and Williams et al. [19], who
found a synergistic relationship between IL-1 and TNF-a. A
positive correlation between TNF-a and phagocyte recruitment
has also been demonstrated [20]. Our results suggest that both
IL-1 and TNF-a are essential for the reactivation response
induced by systemic challenge with PG-APS.
The role of IL-4, IL-10, and interferon-g in the
reactivation response induced by PG-APS
To evaluate the involvement of Th1- and Th2-related mecha-
nisms in the development of the reactivation model, antibodies
to IL-4, interferon-g, or IL-10 were administered as described
above during the reactivation phase of the arthritic response.
Appropriate control antibodies were administered in each
instance. The results shown in Figure 2 indicate that treatment
with antibodies to IL-4 significantly reduced the reactivation
response to PG-APS. Moreover, results from histological analy-
sis indicates that synovial infiltration and damage to the
articular surface were reduced in treated rats (Fig. 3). In
contrast, antibodies to IL-10 or interferon-g had no significant
effect on the inflammatory response. Similar results were also
observed when the antibodies were administered within 7 days
of the initial intraarticular injection (data not shown). These
results suggest that Th2 mechanisms may be operative in this
model and are in contrast with results obtained from other
models and in human arthritis, which indicate that Th1
mechanisms are predominant. For instance, Allen et al. [21]
found that long-term IL-4 treatment in the chronic SCW model
decreased the amount of swelling during the chronic phase. In
addition, interferon-g treatment, depending on the dosing
protocol, triggers the onset of collagen arthritis in mice and
enhances swelling in adjuvant-induced arthritis [22, 23].
However, not all evidence points to a consistent role for Th1
mechanisms in models of arthritis. Alternate treatment proto-
cols in adjuvant arthritis causes transient reduction in ankle
swelling followed by a significant exacerbation. In addition,
interferon-g treatment inhibits the development of CIA and
adjuvant arthritis [24, 25]. Therefore, the participation of Th1
and Th2 mechanisms in models of arthritis remains controver-
sial.
In rheumatoid arthritis, evidence regarding the nature of the
immune response is also inconclusive. Some studies suggest
that Th1-related mechanisms predominate. For instance, mono-
nuclear cells obtained from synovial fluid and subsequently
stimulated in culture demonstrated an increase in interferon-g
and IL-2 biosynthesis [26]. Few cells were found that produce
IL-4. Similarly, T cell clones obtained from synovial tissue were
primarily of the Th1 type [27, 28]. Another study found high
expression of interferon-g relative to IL-4 in the rheumatoid
synovial membrane [29]. However, other studies also indicate
that Th2-related processes are operative. Unstimulated CD41 T
cells from synovial fluid produce large quantities of IL-4 and
IL-10 and deficient levels of interferon-g and IL-2 [30]. In
addition, synovial tissue lymphocytes produce significant quan-
tities of IL-10 [31]. The diverse nature of the immune response
in rheumatoid arthritis may reflect the complex immunoregula-
tory networks that are evident in human disease. The SCW
reactivation model may allow a more precise definition of Th2
mechanisms in arthritis.
Chemokine involvement in the
reactivation response
To explore the role of chemokines in the inflammatory response
induced by reactivation with PG-APS, antibodies to two CC
chemokines, MCP-1 and MIP-1a, or one CXC chemokine,
MIP-2, were administered during the reactivation phase of the
arthritic response. Appropriate control antibodies were admin-
istered in each instance. Results shown in Figure 4 indicate
that all of the antibodies have a significant effect on swelling.
The effects of antibodies to MCP-1 were most pronounced and
Fig. 1. Changes in ankle volume 72 h after the secondary intravenous
injection with PG-APS. Animals were depleted of neutrophils or treated with an
antisera to TNF-a or IL-1a. Control animals received an equivalent amount of
normal serum. Results are shown as the mean 6 SEM (n 5 7/experimental
group).
Fig. 2. Changes in ankle volume 72 h after the secondary intravenous
injection with PG-APS. Animals were treated with antibodies to interferon-g
(IFN-g), IL-4, or IL-10. Control animals received an equivalent amount of
normal serum or normal serum IgG. Results are shown as the mean 6 SEM (n 5
7/experimental group).
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were studied further by evaluating the effects of the antibody on
T cell migration. Antibody treatment significantly reduced T
cell migration into the inflamed joint (results not shown). The
results demonstrate the important role of MCP-1 in the cellular
component of the immune response to PG-APS.
The interrelationship between IL-4 and MCP-1
in the reactivation model
Because previous reports have suggested a connection between
the expression of IL-4 and MCP-1 expression in other models
[32–35], the effect of an antibody to IL-4 on MCP-1 message
expression was evaluated. The antibody was administered
during the reactivation phase as described above. Animals were
killed at various time points and total RNA from the ankle
joints was analyzed by Northern analysis for MCP-1 message.
An appropriate control antibody was used as a control. As the
results in Figure 5 suggest, antibody to IL-4 blocks the
expression of mRNA for MCP-1 at 24 and 72 h after reactiva-
tion. These results indicate a close relationship between IL-4
and the expression of MCP-1, and perhaps help to explain the
anti-inflammatory effect of anti-IL-4 antibodies.
In conclusion, the results from these studies suggest that
reactivation arthritis induced by PG-APS is a Th2-related
immunological response that is tightly regulated by an array of
chemokines, cytokines, and adhesion molecules. In addition to
the involvement of IL-1 and TNF-a, the model is highly
dependent on neutrophils, and swelling is inhibited by antibod-
ies to MIP-2, a chemokine that is chemotactic for neutrophils.
Consistent with Th2-related processes and the neutrophil
dependence of the model, antibodies to IL-4, but not inter-
feron-g, attenuated swelling in the model. This effect appears to
be mediated in part by the inhibitory effects of antibodies to
IL-4 on MCP-1 expression because MCP-1 is critical for both
swelling and T cell infiltration.
Fig. 3. Effect of anti-IL-4 antibody treatment on joint histopathology. (A) Control joint; (B) positive control joint 72 h post-reactivation; (C) 72-h joint treated with
anti-IL-4 antibody. Note the marked reduction in synovial inflammation (arrows) and preservation of joint integrity (arrowheads) in anti-IL-4-treated rats compared
with 72-h positive controls.
Fig. 4. Changes in ankle volume 72 h (48 h for MIP-2) after the secondary
intravenous injection with PG-APS. Animals were treated with antibodies to
MIP-2, MCP-1, or MIP-1a. Control animals received an equivalent amount of
normal serum or normal serum IgG. Results are shown as the mean 6 SEM (n 5
7/experimental group).
Fig. 5. Changes in expression of MCP-1 mRNA levels 24 and 72 h after the
secondary intravenous injection of PG-APS. Animals were treated with
antibodies to IL-4. Control animals received an equivalent amount of normal
serum IgG. A representative experiment is shown.
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